教職人員
|
楊泮池
研究領域：藥理學科
本職：臺大內科醫師
Stage shifts in national lung adenocarcinoma and the impact of opportunistic self-initiated LDCT screening in Taiwan: a nationwide population-based cohort study.
(2026-06) Wu, Jia-Jun ; CHUN-JU CHIANG ; Chen, Chia-Hung ; Tseng, Jeng-Sen ; Feng, Po-Hao ; Yang, Ya-Wen ; Zheng, Zhe-Rong ; Chu, Cheng-Hsiang ; Yang, Chih-Jen ; Chong, Inn-Wen ; Tu, Chih-Yen ; WEN-CHUNG LEE ; Hsia, Jiun-Yi ; Chen, Kun-Chieh ; PAN-CHYR YANG ; SUNG-LIANG YU ; Chang, Gee-Chen
Author Correction: Innovative approaches for lung cancer screening and interception.
(2026-05) Zhang, Jianjun ; Park, Matthew D ; Pandya, Tej ; Shum, Elaine ; Wu, Jia ; Heeke, Simon ; Salehi-Rad, Ramin ; Marron, Thomas U ; Wei, Zhubo ; Li, Hui ; Blum, Torsten G ; Heymach, John V ; Dubinett, Steven M ; PAN-CHYR YANG ; Swanton, Charles ; Merad, Miriam
pH-responsive virus-drug conjugates for targeted PD-L1 silencing and enhanced cancer immunotherapy.
(2026-03-30) Tseng, S-Ja ; Kempson, Ivan M ; Ho, Yi-Cheng ; PAN-CHYR YANG ; Liao, Zi-Xian
Innovative approaches for lung cancer screening and interception.
(2026-02-23) Zhang, Jianjun ; Park, Matthew D ; Pandya, Tej ; Shum, Elaine ; Wu, Jia ; Heeke, Simon ; Salehi-Rad, Ramin ; Marron, Thomas U ; Wei, Zhubo ; Li, Hui ; Blum, Torsten G ; Heymach, John V ; Dubinett, Steven M ; PAN-CHYR YANG ; Swanton, Charles ; Merad, Miriam
Global advances and future directions in lung cancer care: expert consensus and strategic priorities.
(2026-02) Meyer, M-L ; Peters, S ; Jänne, P A ; Mok, T S ; Bunn, P A ; Abdel Karim, N ; Altorki, N K ; Arrieta, O ; Bar, J ; Cappuzzo, F ; Carbone, D ; Dacic, S ; Diehn, M ; Dziadziuszko, R ; Felip, E ; Flores, R ; Florez, N ; Forde, P M ; Gainor, J F ; Gray, J E ; Gros, L ; Halmos, B ; Henschke, C I ; Herbst, R ; Heymach, J V ; Kelly, K ; Kris, M G ; Leighl, N B ; Mathias, C ; Marron, T U ; Mulshine, J L ; Naidoo, J ; Osarogiagbon, R ; Passaro, A ; Peled, N ; Planchard, D ; Politi, K ; Popat, S ; Pyenson, B ; Reckamp, K L ; Ren, S H ; Riely, G J ; Rolfo, C ; Rudin, C M ; Sen, T ; Shields, M D ; Singh, H ; Skoulidis, F ; Solomon, B J ; Stahel, R ; Stiles, B M ; Syrigos, K ; CHIH-HSIN YANG ; PAN-CHYR YANG ; Wolf, A ; Wozniak, A J ; Waqar, S N ; Wakelee, H ; Hirsch, F R
(2026-06) Wu, Jia-Jun ; CHUN-JU CHIANG ; Chen, Chia-Hung ; Tseng, Jeng-Sen ; Feng, Po-Hao ; Yang, Ya-Wen ; Zheng, Zhe-Rong ; Chu, Cheng-Hsiang ; Yang, Chih-Jen ; Chong, Inn-Wen ; Tu, Chih-Yen ; WEN-CHUNG LEE ; Hsia, Jiun-Yi ; Chen, Kun-Chieh ; PAN-CHYR YANG ; SUNG-LIANG YU ; Chang, Gee-Chen
Author Correction: Innovative approaches for lung cancer screening and interception.
(2026-05) Zhang, Jianjun ; Park, Matthew D ; Pandya, Tej ; Shum, Elaine ; Wu, Jia ; Heeke, Simon ; Salehi-Rad, Ramin ; Marron, Thomas U ; Wei, Zhubo ; Li, Hui ; Blum, Torsten G ; Heymach, John V ; Dubinett, Steven M ; PAN-CHYR YANG ; Swanton, Charles ; Merad, Miriam
pH-responsive virus-drug conjugates for targeted PD-L1 silencing and enhanced cancer immunotherapy.
(2026-03-30) Tseng, S-Ja ; Kempson, Ivan M ; Ho, Yi-Cheng ; PAN-CHYR YANG ; Liao, Zi-Xian
Innovative approaches for lung cancer screening and interception.
(2026-02-23) Zhang, Jianjun ; Park, Matthew D ; Pandya, Tej ; Shum, Elaine ; Wu, Jia ; Heeke, Simon ; Salehi-Rad, Ramin ; Marron, Thomas U ; Wei, Zhubo ; Li, Hui ; Blum, Torsten G ; Heymach, John V ; Dubinett, Steven M ; PAN-CHYR YANG ; Swanton, Charles ; Merad, Miriam
Global advances and future directions in lung cancer care: expert consensus and strategic priorities.
(2026-02) Meyer, M-L ; Peters, S ; Jänne, P A ; Mok, T S ; Bunn, P A ; Abdel Karim, N ; Altorki, N K ; Arrieta, O ; Bar, J ; Cappuzzo, F ; Carbone, D ; Dacic, S ; Diehn, M ; Dziadziuszko, R ; Felip, E ; Flores, R ; Florez, N ; Forde, P M ; Gainor, J F ; Gray, J E ; Gros, L ; Halmos, B ; Henschke, C I ; Herbst, R ; Heymach, J V ; Kelly, K ; Kris, M G ; Leighl, N B ; Mathias, C ; Marron, T U ; Mulshine, J L ; Naidoo, J ; Osarogiagbon, R ; Passaro, A ; Peled, N ; Planchard, D ; Politi, K ; Popat, S ; Pyenson, B ; Reckamp, K L ; Ren, S H ; Riely, G J ; Rolfo, C ; Rudin, C M ; Sen, T ; Shields, M D ; Singh, H ; Skoulidis, F ; Solomon, B J ; Stahel, R ; Stiles, B M ; Syrigos, K ; CHIH-HSIN YANG ; PAN-CHYR YANG ; Wolf, A ; Wozniak, A J ; Waqar, S N ; Wakelee, H ; Hirsch, F R
Develop an Innovative Drug Discovery Platform Targeting Kras Mutation-Driven Resistance in Lung Adenocarcinoma = 開發設計新穎藥物平台，針對KRAS突變產生抗藥性之肺腺癌
(2025-08-01～) PAN-CHYR YANG
Development of Novel Phagocytosis Therapeutic Antibody for Lung Cancer (III) = 開發促腫瘤細胞吞噬的新穎性肺癌治療抗體 (III)
(2025-08-01～) PAN-CHYR YANG
Development of Novel Phagocytosis Therapeutic Antibody for Lung Cancer (II) = 開發促腫瘤細胞吞噬的新穎性肺癌治療抗體 (II)
(2024-08-01～) PAN-CHYR YANG
Gps-Based High-Throughput Screening of Drugs Modulating Tumor Microenvironment - Pd-L1 as Targets for Cancer Immunotherapy (III) = 利用高通量蛋白穩定度藥物篩選技術(GPS)對腫瘤微環境中蛋白調控進行新藥開發 - 以PD-L1免疫治療為例 (III)
(2024-08-01～) PAN-CHYR YANG
Development of Novel Phagocytosis Therapeutic Antibody for Lung Cancer (I) = 開發促腫瘤細胞吞噬的新穎性肺癌治療抗體 (I)
(2023-08-01～) PAN-CHYR YANG
(2025-08-01～) PAN-CHYR YANG
Development of Novel Phagocytosis Therapeutic Antibody for Lung Cancer (III) = 開發促腫瘤細胞吞噬的新穎性肺癌治療抗體 (III)
(2025-08-01～) PAN-CHYR YANG
Development of Novel Phagocytosis Therapeutic Antibody for Lung Cancer (II) = 開發促腫瘤細胞吞噬的新穎性肺癌治療抗體 (II)
(2024-08-01～) PAN-CHYR YANG
Gps-Based High-Throughput Screening of Drugs Modulating Tumor Microenvironment - Pd-L1 as Targets for Cancer Immunotherapy (III) = 利用高通量蛋白穩定度藥物篩選技術(GPS)對腫瘤微環境中蛋白調控進行新藥開發 - 以PD-L1免疫治療為例 (III)
(2024-08-01～) PAN-CHYR YANG
Development of Novel Phagocytosis Therapeutic Antibody for Lung Cancer (I) = 開發促腫瘤細胞吞噬的新穎性肺癌治療抗體 (I)
(2023-08-01～) PAN-CHYR YANG